PhD Neuroscience 🧠 | CEO for Australian Biopharma Company - Neurotech International Ltd. (ASX: NTI)
🤝 Investor Relations & Stakeholder Engagement
🔬 Clinical Trial design
🌱 Medicinal Cannabis
🧠 Neurological Diseases including Autism
Other interests:
💡other biotech/ biopharma
💡investing
💡neurofinance / behavioural finance
💡productivity
💡brain health, neuroplasticity
🎨🏊♀️👟🧶💃🧠✈️
Invited by: Michael Winlo
if the data has not been changed, no new rows will appear.
| Day | Followers | Gain | % Gain |
|---|---|---|---|
| April 22, 2024 | 1,019 | +3 | +0.3% |
| February 04, 2024 | 1,016 | +1 | +0.1% |
| January 18, 2024 | 1,015 | +2 | +0.2% |
| December 02, 2023 | 1,013 | -2 | -0.2% |
| October 03, 2023 | 1,015 | +1 | +0.1% |
| September 26, 2023 | 1,014 | +14 | +1.5% |
| January 24, 2022 | 1,000 | +67 | +7.2% |
| December 18, 2021 | 933 | +13 | +1.5% |
| November 09, 2021 | 920 | +11 | +1.3% |
| October 02, 2021 | 909 | +41 | +4.8% |